Skip to content

Relationship Between Oxidative Stress and Aortic Stiffness

Relationship Between Oxidative Stress and Aortic Stiffness During Acute Exhaustive Training in Adolescent Football Players

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06590792
Enrollment
43
Registered
2024-09-19
Start date
2025-05-30
Completion date
2025-07-15
Last updated
2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stiffness, Football Player, Oxidative Stress

Keywords

stiffness, elastography, football, oxidative stress

Brief summary

The goal of this clinical trial is to search about if there is any relationship between the aortic stiffness and oxidative stress response in adolescent football players. The main questions are; * Is there any difference between the adolescent football players and healthy sedentary control group in terms of oxidative stress and aortic stiffness parameters? * Is there any relationship between the aortic stiffness and oxidative response to acute exercise training in adolescent male football players? Participants will perform acute exhaustive exercise training. Venous blood will be drained before and after exercise training. Oxidative parameters will be measured.

Detailed description

Arterial stiffness is defined as stiffening of the arterial wall and refers to a decrease in the capacity of an artery to expand and contract in response to pressure changes in the vessel. The parameters indicating arterial stiffness are compliance and distensibility of the vessel. Imbalance in the formation of vasodilator and vasoconstrictor signaling molecules acting on the vessel is an important determining factor in the development of endothelial dysfunction, which is often exacerbated by oxidative stress. Disruption of the balance between oxidants and antioxidants in favor of oxidants leads to disruption of the elastin-collagen ratio in the vessel wall in favor of collagen and ultimately to the development of arterial stiffness. Regular exercise is beneficial both to prevent the development of arterial stiffness and to reduce arterial stiffness. Although many mechanisms have been mentioned for exercise to improve endothelial function, there is no clear consensus on the mechanisms by which exercise increases arterial compliance, which is one of the indicators of atherosclerosis. While the beneficial impacts of physical activity on arterial stiffness are well-documented, this varies considerably among sports disciplines. For instance, there are studies showing that endurance training decreases arterial stiffness in young adults and elderly individuals, whereas strength training increases arterial stiffness. Arterial stiffness is lower in endurance athletes with a longer sports history and higher in those with a strength training history. The weekly training time of competitive young athletes is well beyond the amount of exercise required for healthy living. It has also been suggested that this excessive amount of time may trigger some unfavorable adaptations in the cardiovascular system. In addition, the number of studies examining the effects of regular exercise training at these levels on the vascular system is limited. Studies indicate that changes in arterial stiffness start at early ages and this is also true for young athletes who perform regular training in the infrastructures of various sports branches. Therefore, our aim is investigating the relationship between the oxidative stress parameters and aortic stiffness in adolescent male football players and comparing with the healthy control group. Secondly, the investigators will evaluate if there is any difference between the aortic stiffness and oxidative response to acute exercise training in adolescent male football players?

Interventions

OTHERexhaustive exercise training session

Cardiovascular exercise test will be performed by the participants. This test is sustained until the participants feel exhausted.

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Echocardiographer and biochemistry expert will be blind to participants type (sedentary or football player)

Intervention model description

Two groups including 20 participants in each of them will be involved the study. One group will consist of adolescent football players, while the other group will consist of non-athlete healthy participants

Eligibility

Sex/Gender
MALE
Age
14 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* age between 14-18 * male gender * football player * attending regular football training for at least 1 season

Exclusion criteria

* female gender * attending any other sports training except from football * having any chronic disease * having any musculoskeletal disease which limits to join exhaustive exercise training

Design outcomes

Primary

MeasureTime frameDescription
aortic strain (%)will be measured twice before and after acute exhaustive exercise, through study completion, up to 8 weeks=\[(aortic systolic diameter - diastolic diameter)× 100\] / aortic diastolic diameter
aortic stiffness indexwill be measured twice before and after acute exhaustive exercise,through study completion, up to 8 weeks= ln (systolic pressure / diastolic pressure) / aortic strain
aortic distensibility (cm2.dyn-1.10-6)will be measured twice before and after acute exhaustive exercise,through study completion, up to 8 weeks= (2 × aortic strain) / (systolic pressure-diastolic pressure)
serum lipid hydroperoxide assaywill be measured twice before and after acute exhaustive exercise,through study completion, up to 8 weekslipid hydroperoxide (LHP) level of serum (nmol/mL). Lipid hydroperoxide (LOOH) is the first, comparatively stable, product of the lipid peroxidation reaction.
serum malondialdehide assaywill be measured twice before and after acute exhaustive exercise,through study completion, up to 8 weeksserum malondialdehide (MDA) level of serum (nmol/mL).MDA is the end product of the oxidation of polyunsaturated fatty acids.
serum advanced oxidation protein products assaywill be measured twice before and after acute exhaustive exercise,through study completion, up to 8 weeksAdvanced oxidation protein products (AOPP) level of serum (mikromol/L ). AOPP are the dityrosine-containing and crosslinking protein products formed during oxidative stress by reaction of plasma protein with chlorinated oxidants, and often carried by albumin in vivo
serum advanced glycation end products assaywill be measured twice before and after acute exhaustive exercise,through study completion, up to 8 weeksserum advanced glycation end products (AGE) level of serum(FU/mg). AGEs are are a heterogeneous group of proteins and lipids, formed by nonenzymatic glycation after persistent contact with aldose sugars
serum ferric reducing antioxidant power assaywill be measured twice before and after acute exhaustive exercise, through study completion, up to 8 weeksferric reducing antioxidant power (FRAP) level of serum (mikromol/mL ). FRAP is an antioxidant capacity assay that uses Trolox as a standard
serum superoxide dismutase activity assaywill be measured twice before and after acute exhaustive exercise,through study completion, up to 8 weekscopper-zinc superoxide dismutase activity (SOD) level of serum (U/mL). SODs are enzymes that catalyze the conversion of naturally-occuring but harmful superoxide radicals into molecular oxygen and hydrogen peroxide
serum total antioxidant status and total oxidant status assaywill be measured twice before and after acute exhaustive exercise,through study completion, up to 8 weekstotal antioxidant status (TAS) and total oxidant status (TOS) levels of serum (trolox equivalent/L) are two indicators to determine all antioxidants or oxidants in samples, which can more comprehensively reflect the changes of oxidant and antioxidant capacity of samples

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026